Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus
about
Genes, tolerance and systemic autoimmunityUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaMolecular and Cellular Characterization of Human CD8 T Suppressor CellsGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitusPathogenesis of human systemic lupus erythematosus: recent advances.CD8+ Tregs in lupus, autoimmunity, and beyond.Differential expression of serine-threonine kinase receptor-associated protein in patients with systemic lupus erythematosus.T cells as therapeutic targets in SLE.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cellsImmunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.CD4+CD25+ T regulatory cells from FIV+ cats induce a unique anergic profile in CD8+ lymphocyte targetsLactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis.Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses.The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 TherapyMegakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigensHaematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationCD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.CD8⁺ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria.Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus.Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.Moving to tolerance: clinical application of T regulatory cellsImmune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis.Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option?Emerging concepts in haematopoietic cell transplantation.Gut immune system and oral tolerance.The role of regulatory T cells in the biology of graft versus host disease.Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.Induced regulatory T cells in inhibitory microenvironments created by cancer.Stem cell autograft and allograft in autoimmune diseases.Stem cell therapies for systemic lupus erythematosus: current progress and established evidence.
P2860
Q24615454-4C84FA5B-84C7-4C42-83BF-1A82C6563CE1Q26777402-6FCFC323-1196-4A5D-93CB-256C5EDC4A0DQ28066113-4A952347-A764-46EB-8797-A5D53A7D392DQ30276550-6300B445-58D2-4E60-ABD5-C9389102129AQ30582614-DD3B56C3-3A48-489C-B7C8-306098767CB7Q33576368-9F75CCE8-C8A4-47AC-BCEB-368BBF4DF463Q33664927-5D46695B-9ED6-4C24-B732-CC95BF5776BAQ33889097-ED182728-3605-47B8-97A3-4CF9669DB1B9Q33912357-E0DE02ED-28EE-4C2A-9668-BB670E8AEBB2Q34075552-C5816FC0-710E-41BE-8432-5A4B4045A430Q34110557-DBDDF21D-F030-4A26-9BFA-F805C1BE166FQ34291105-27C7BE19-AAD3-463D-A4F4-6E0FC066228AQ34380052-B3861AEC-3FF7-4F87-94DF-094A0B21DC3AQ34598916-CA3F2433-5F3B-4F1B-9D8B-27A982550B69Q34785104-4C1890CC-AB64-4CDA-9D4D-FABD929F8152Q35074594-6E455896-C587-4DE0-9999-14169D135935Q35201052-63438A1C-601A-4D8C-A9F5-B100665621D5Q35400555-0D537EA0-3686-4D20-A693-F6684C5F4530Q35426986-C8C7F4E6-0A7E-4246-8689-DF3D899DB429Q36016443-C9523D20-DAF4-4802-B47A-C777C178AA53Q36020897-5EAD4C4E-600C-4FBF-ABF1-C5EAE6EDE608Q36055096-65480BA2-8B53-41B2-9289-2E8330A29DDFQ36788495-C8AFDA78-EC04-4DFA-83A7-E280D318E9A2Q37124529-8749B9B5-DE36-4644-8A5B-37F807B5064DQ37221779-30E94F34-279A-402F-A831-B71AD9E87FC4Q37361089-B273864E-63E3-45E8-9B8A-EE0226692ADDQ37520543-2314251D-C5DE-4D14-B40D-C3A350B04728Q37582300-4E3052F7-8231-4B80-BA4E-7F1ECD7C12B8Q37590759-7929CC26-D201-483E-B31F-2179A4863222Q37616428-6B298881-E233-4DFF-8305-2059B6759B0FQ37881151-ACA0A77B-1AFA-4E68-9C95-73790B441AA2Q37929621-0348F874-8F99-4BAB-BCDC-6D69E7109EE5Q38004048-5502B500-00B5-43AA-88B0-36F5BDB9A61CQ38013047-A05FEAFC-A104-43E3-9C5E-C01A87D99CF2Q38077631-B742A8A0-8B73-40F5-BF2C-FFC94A9CDC5FQ38117369-5749A873-7B24-4146-9A35-E508D7A7CAC8Q38198735-E57CCE5B-7CF3-4D23-9DEB-DFE59C6414D2Q38220701-32A4C162-0AAB-4982-8454-E7387155949DQ38287103-1730774C-9EDF-437C-9224-67630B29B3A0Q38431886-7EA04E79-EEF3-479C-82A2-1BA48A530BBF
P2860
Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulatory T cell (Treg) subse ...... munological remission of lupus
@en
Regulatory T cell (Treg) subse ...... unological remission of lupus.
@nl
type
label
Regulatory T cell (Treg) subse ...... munological remission of lupus
@en
Regulatory T cell (Treg) subse ...... unological remission of lupus.
@nl
prefLabel
Regulatory T cell (Treg) subse ...... munological remission of lupus
@en
Regulatory T cell (Treg) subse ...... unological remission of lupus.
@nl
P2093
P2860
P356
P1476
Regulatory T cell (Treg) subse ...... munological remission of lupus
@en
P2093
Anne M Bertucci
Richard K Burt
Rosalind Ramsey-Goldman
Syamal K Datta
P2860
P304
P356
10.4049/JIMMUNOL.0901773
P407
P577
2009-10-19T00:00:00Z